Events
Conferences, congresses and webinars where Philogen presents its science.
3rd ShanghaiTech-SIAIS BioForum
Philogen S.p.A. and its fully owned subsidiary Philochem AG, announce their participation to the “3rd ShanghaiTech-SIAIS BioForum”, 7-10 November 2016…
World Immunotherapy Congress 2016
Philogen S.p.A. announces participation in the “World Immunotherapy Congress 2016”, 14 – 16 November 2016, Basel, Switzerland
PEGS Europe – Protein & Antibody Engineering Summit
Philogen S.p.A announces participation in “PEGS Europe – Protein & Antibody Engineering Summit” , 31 October – 4 November 2016, Lisbon, Portugal
XXIV EFMC INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY
Philogen S.p.A. announces participation in “XXIV EFMC INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY”, 28 August – 1 September 2016, Manchester, UK
Dario Neri, the co-founder and Chairman of the Scientific Advisory Board presented at the 11th Annual European Antibody Congress in Basel, Switzerland, 9th-11th November.
Dario Neri, the co-founder and Chairman of the Scientific Advisory Board presented at the 11th Annual European Antibody Congress in Basel, Switzerland, 9th-11th…
Dario Neri, the co-founder and chairman of the scientific advisory board of Philogen will deliver the keynote speech at the First Boston Symposium of Encoded Library Platforms in Boston
Dario Neri, the co-founder and chairman of the scientific advisory board of Philogen will deliver the keynote speech at the First Boston Symposium of Encoded…
Philogen. Data from Phase Ib clinical trial of Dekavil in rheumatoid arthritis
Philogen. Data from Phase Ib clinical trial of Dekavil in rheumatoid arthritis were presented at the 4th Israel-Italy Meeting of Autoimmunity and…
Philogen presented “Dekavil (F8-IL10)
Philogen presented “Dekavil (F8-IL10), a novel therapeutic approach for rheumatoid arthritis: ongoing Phase Ib clinical trial results.” at EULAR Rome 2015. Rome…
Giulio Casi presented “Targeting disease with armed antibodies and small molecule drug conjugates.”
Giulio Casi presented “Targeting disease with armed antibodies and small molecule drug conjugates.” at SMI ADC Summit 2015. London (UK), 18th-19th May, 2015.
Dario Neri presented “Arming tumor-targeting antibodies with cytokine payloads: Emerging clinical results.”
Dario Neri presented “Arming tumor-targeting antibodies with cytokine payloads: Emerging clinical results.” at PEGS (Essential Protein Engineering Summit) 2015…
Dario Neri presented “Arming tumor-targeting antibodies with cytokine payloads: Emerging clinical results.”
Dario Neri presented “Arming tumor-targeting antibodies with cytokine payloads: Emerging clinical results.” at AACR Annual Meeting 2015. Philadelphia (USA)…
Mattia Matasci presented “Targeting disease with armed antibodies small molecule drug conjugates”
Mattia Matasci presented “Targeting disease with armed antibodies small molecule drug conjugates” at Antibody Targeted-drug conjugates 2015. Porto (Portugal)…
Dario Neri presented “Antibody-cytokine fusion proteins: from the bench to the clinic”
Dario Neri presented “Antibody-cytokine fusion proteins: from the bench to the clinic” at 1st International Symposium for Medicinal Sciences organized by the…
Philogen was present at BIO-Europe Spring® Conference. Paris (France), 9th-11th March.
Philogen was present at BIO-Europe Spring® Conference. Paris (France), 9th-11th March.
Giulio Casi – presented “Arming disease-targeting ligands with cytokines and cytotoxic drugs”
Giulio Casi – presented “Arming disease-targeting ligands with cytokines and cytotoxic drugs” at World ADC Conference. Frankfurt (DE), 24th-25th February.
Dario Neri – presented “Immunocytokines for the Therapy of Cancer and of Chronic Inflammation”
Dario Neri – presented “Immunocytokines for the Therapy of Cancer and of Chronic Inflammation” at Biochemical Pharmacology Discussion Group (NY Academy…